Evidence map›Paper›PMID 38891938›Full record

ReviewInternational journal of molecular sciences2024

The Use of Compounds Derived from

Anna Stasiłowicz-Krzemień, Wiktoria Nogalska, Zofia Maszewska, Mateusz Maleszka, Maria Dobroń, Agnieszka Szary, Aleksandra Kępa, Marcin Żarowski, Katarzyna Hojan, Malgorzata Lukowicz and 1 more

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Comparative Anti-Obesity Potential of Cannabigerol-DominantInternational journal of molecular sciences · 2026
    Article
  4. Article
  5. HarnessingPharmaceutics · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Anna Stasiłowicz-KrzemieńDepartment of Pharmacognosy and Biomaterials, Faculty of Pharmacy, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznan, Poland.ORCID 0000-0001-5211-661X
Wiktoria NogalskaDepartment of Pharmacognosy and Biomaterials, Faculty of Pharmacy, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznan, Poland.
Zofia MaszewskaDepartment of Pharmacognosy and Biomaterials, Faculty of Pharmacy, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznan, Poland.
Mateusz MaleszkaDepartment of Pharmacognosy and Biomaterials, Faculty of Pharmacy, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznan, Poland.
Maria DobrońDepartment of Pharmacognosy and Biomaterials, Faculty of Pharmacy, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznan, Poland.
Agnieszka SzaryDepartment of Pharmacognosy and Biomaterials, Faculty of Pharmacy, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznan, Poland.
Aleksandra KępaDepartment of Pharmacognosy and Biomaterials, Faculty of Pharmacy, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznan, Poland.
Marcin ŻarowskiDepartment of Developmental Neurology, Poznan University of Medical Sciences, Przybyszewski 49, 60-355 Poznan, Poland.ORCID 0000-0002-9800-9446
Katarzyna HojanDepartment of Occupational Therapy, Poznan University of Medical Sciences, Swięcickiego 6, 61-847 Poznan, Poland.ORCID 0000-0002-6166-9424
Malgorzata LukowiczDepartment of Rehabilitation, Centre of Postgraduate Medical Education, Konarskiego 13, 05-400 Otwock, Poland.
Judyta Cielecka-PiontekDepartment of Pharmacognosy and Biomaterials, Faculty of Pharmacy, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznan, Poland.ORCID 0000-0003-0891-5419

Funding

National Science Center UMO-2021/41/N/NZ7/01125
6 · The paper itself

Abstract

Neurological disorders present a wide range of symptoms and challenges in diagnosis and treatment.

Indexed as

CannabisEpilepsyNeurodegenerative DiseasesAnalgesicsAnimalsAnticonvulsantsCannabinoidsHumansMental DisordersNeuroprotective AgentsPainPlant ExtractsAnalgesicsAnticonvulsantsCannabinoidsNeuroprotective AgentsPlant ExtractscannabidiolcannabisCannabis sativaneurological disorderstetrahydrocannabinol

Identifiers

PMID38891938
PMCPMC11171823

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.